InflaRx N.V. [3,000,000] Common Shares Underwriting AgreementUnderwriting Agreement • May 2nd, 2018 • InflaRx N.V. • Pharmaceutical preparations • New York
InflaRx N.V., a public limited liability company (naamloze vennootschap) under Dutch law, (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [1,500,000] common shares with a nominal value of €0.12 per share in the capital of the Company (the “Common Shares”) and certain shareholders of the Company named in Schedule 2 hereto (the “Selling Shareholders”) propose to sell to the several Underwriters an aggregate of [1,500,000] Common Shares of the Company (collectively, the “Underwritten Shares”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional [350,000] Common Shares of the Company and the Selling Shareholders propose to sell, at the option of the Underwriters, up to an additional [100,000] Common Shares of the Company (collectively, the “Option Shares”). The Underwritten Share
